What Happens When No One Is Watching?

Mintz comments on the decline of Congressional oversight on the Food and Drug Administration (FDA). He contends that FDA had become a partner rather than a watchdog of the pharmaceutical industry. But House leaders had no interest in investigating the FDA's role in approving even one of the drugs that caused needless deaths and injuries or in determining what led up to $13 billion in legal claims and costs. Least of all did they want to investigate why and how the FDA had become a partner of an industry that has more lobbyists than Congress has members, that was filling the campaign coffers of friendly lawmakers to overflowing, and that held out the prospect of high-paying jobs for overseers who wouldn't oversee.